Clinical Trial Update: Adjunctive Study of AL-37807 Ophthalmic Suspension [Phase 2]

View source ↗

Summary

A Phase 2 adjunct study of AL-37807 ophthalmic suspension for open-angle glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AL-37807 Ophthalmic Suspension (AL-37807)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED